Navigation Links
CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford
Date:11/11/2009

John Crowley, a featured Keynote at this year's Molecular Medicine Tri-Conference, is the inspiration for a new film which will find its way onto the big screen January 22.

Needham, Mass. (PRWEB) November 11, 2009 -- Cambridge Healthtech Institute's (CHI) flagship event, the Molecular Medicine Tri-Conference (February 3-5, 2010) will feature inspirational Keynote John F. Crowley, Founder, Novazyme Pharmaceuticals, Inc.

Mr. Crowley, a Harvard educated businessman, created and built a pharmaceutical company devoted entirely to finding a cure for Pompe disease. He will detail his journey through the labyrinth of scientific and business fronts, which lead up to a first-round clinical trial.

In 1998, two of John Crowley's three children were diagnosed with Pompe disease, a rare and fatal neuromuscular disorder that affects only several thousand children worldwide. After his children were given months to live, and being told there was nothing to be done, John began his incredible journey to find a cure for this fatal disease.

Originally dismissed by virtually all in the biotechnology industry as having no chance of success, Novazyme quickly grew to a 100-person company. Crowley, as CEO of Novazyme, commuted weekly from his home in Princeton, NJ, to Oklahoma City. He raised over $27 million in venture capital on Wall Street for Novazyme in less than a year. Within 18 months of his helping Dr. Canfield to start Novazyme, he agreed for Novazyme to be acquired by Genzyme Corporation, the world's third largest biotechnology company, for a price of $225 million, one of the largest amounts ever paid for a pre-clinical drug development company in biotechnology history.

John Crowley's remarkable story will be released in a film starring Harrison Ford and Brendan Fraiser in January 2010, Extraordinary Measures. An uplifting, inspirational drama, it is based on a Wall Street Journa
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
2. News from the November/December Issue of Molecular Medicine
3. National Jewish Health Developing a Molecular Roadmap for Chronic Lung Diseases
4. bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID(R) Molecular Cancer Classifier in United Kingdom, Ireland and Middle East Countries
5. Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis
6. Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics
7. Molecular imaging holds promise for early intervention in common uterine cancer
8. Reportlinker Adds Whos Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report
9. Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report
10. News from the Latest Issue of Molecular Medicine
11. Inner workings of molecular thermostat point to pathways to fight diabetes, obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... into the metabolism of stromal support cells and immune ... these cell types in the development of diseases ... and cancer. That was the conclusion of a review ... the leading journal Nature . , Prof. Peter ... call. The metabolism of cancer cells has been examined ...
(Date:7/9/2014)... The Miriam Hospital have found that people with ... depressed have difficulty sticking to a pulmonary rehabilitation ... women, and screening and brief treatment of depression ... study and its findings are published in print ... obstructive pulmonary disease is a common and often ...
(Date:7/9/2014)... from Montefiore Medical Center and the ... will present new findings at the Alzheimer,s Association International ... in Copenhagen, Denmark. Data from the four abstracts will ... normality to mild cognitive impairment and dementia. The research ... established in 1980 to examine healthy brain aging as ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
(Date:7/9/2014)... age with kidney and heart disease have raised concerns ... adults. However, in the first study to look closely ... Medicine at the University of Pennsylvania report that older ... expectancy and cardiovascular health as very healthy older people ... the ever increasing organ transplant waitlists, the authors of ...
Breaking Medicine News(10 mins):Health News:Wake-up call for more research into cell metabolism 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2
... in effort to drop pounds, experts say , TUESDAY, Nov. ... exercise and diet are crucial. But a new study says ... the number of TVs in your house and the presence ... out as a stronger factor than we would have anticipated," ...
... Nov. 3 EntreMed, Inc. (Nasdaq: ENMD ... the treatment of cancer today announced presentations for ... AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ... Boston, Massachusetts. Presentations are listed below. , ...
... China, Nov. 3 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore Ltd. (NYSE: ... chain in China based on the number of directly operated ... agreement,with ATMU (China) Technology Co., Ltd., a subsidiary of ATMU ... ATMs in Nepstar stores. , This ...
... 44-year-old woman will celebrate many future birthdays thanks to the ... for breast cancer. , Dr. Sweeten, a board-certified gynecologist and ... incorporated the Provista Life Science BT Test®, a blood test ... practice. Sweeten noted a case where a 44-year-old patient called ...
... ... the Health IT Standards Committee hearing held in Washington, D.C. last week, which was a ... ... Health Inc. endorses and commends the efforts of the Health IT Standards Committee hearing ...
... ... Oven for PTA and PTCA Catheters is Compact, Easy to Operate and Cost Effective ... Laguna Niguel, ... provides a cost-effective approach to heat treating of wrapped balloons on balloon catheters ...
Cached Medicine News:Health News:Living With Less TV, More Sweat Boosts Weight Loss 2Health News:Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference 2Health News:Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference 3Health News:China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores 2Health News:China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores 3Health News:A Breast Cancer Test That Saves Lives 2Health News:A Breast Cancer Test That Saves Lives 3Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 2Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 3Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 4Health News:Interface new Balloon Catheter Solutions PTA and PTCA Catheters 2
(Date:1/14/2014)... /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System - a ... to place and insert the screw accurately - offers ... ligament) repair or reconstruction as it holds the bones ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw ...
(Date:1/14/2014)... Jan. 14, 2014 NineSigma , Inc., the ... Innovation Leadership Summit , May 14-16, 2014 at ... Cleveland Ohio . This is ... committed to breakthrough achievements through open innovation. Participants will ...
(Date:1/14/2014)... 2014   Evidera , a leading provider of evidence-based ... for Drug Evaluation and Research (CDER), U.S. Food and ... document for a patient-reported outcome (PRO) measure in drug ... Tool [EXACT] for Measurement of Symptoms of Acute Bacterial ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Schein, Inc. (Nasdaq: HSIC ), the largest provider ... today that it will release its first quarter 2011 financial ... 2011, and will provide a live webcast of its earnings ... Eastern Daylight Time. Speakers on the call will include Stanley ...
... NASHVILLE, Tenn., April 19, 2011 Cumberland Pharmaceuticals ... pharmaceutical company focused on hospital acute care and gastroenterology ... agreement to acquire the rights to ifetroban, a new ... development under the brand name Hepatoren™ (ifetroban) Injection and ...
Cached Medicine Technology:Henry Schein to Webcast First Quarter 2011 Conference Call Tuesday, May 3, at 10:00 a.m. EDT 2Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 2Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 3Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 4
Straight shafts with 4 mm platform. Wide serrated handle with dull finish. Platform straight....
Curved shafts with 2 mm angled platform. Wide serrated handle with dull finish....
Straight shafts with micro tips and sandblast finish. Insulated smooth handle....
Double-ended. 12 mm bayonet shaped blade. 10 mm curved blade....
Medicine Products: